flavanone has been researched along with imiquimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Alalaiwe, A; Chen, EL; Fang, JY; Hsiao, CY; Lien, WC; Lin, CF; Lin, CY | 1 |
2 other study(ies) available for flavanone and imiquimod
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Female; Flavanones; Humans; Imiquimod; Keratinocytes; Mice; Models, Biological; Models, Molecular; Permeability; Psoriasis; Skin; Skin Absorption; Specific Pathogen-Free Organisms; Structure-Activity Relationship; Swine; Water Loss, Insensible | 2020 |